Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01761006 · ClinicalTrials.gov registry record
Evaluation of FeNO During and Following Acute COPD Exacerbation
A clinical trial, sponsored by Wake Forest University.
- Terminated
- Registry status
- 10
- Enrollment target
NCT01761006 is a clinical trial that was terminated before completion, run by Wake Forest University. The registered enrollment target is 10 participants.
The verdict
NCT01761006 was terminated before completion, sponsored by Wake Forest University.
- TERMINATED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine whether exhaled nitric oxide (FeNO) goes up during an acute exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD) and whether the level of exhaled nitric oxide returns to normal in the weeks after an exacerbation.
Interventions
- DEVICE NIOX MINO®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2013-03 |
| Est. Completion | 2014-09-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01761006
The ClinicalTrials.gov registry entry for NCT01761006 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University, which has 100 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NIOX MINO® is the first listed.
NCT01761006 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01761006 about?
NCT01761006 is a clinical study titled "Evaluation of FeNO During and Following Acute COPD Exacerbation". The purpose of this research study is to determine whether exhaled nitric oxide (FeNO) goes up during an acute exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD) and whether the level of exhaled nitric oxide returns to normal in the weeks after an exacerbation.
What is the current status of trial NCT01761006?
This trial is currently terminated. The enrollment target is 10 participants. The study started on 2013-03. Estimated completion is 2014-09-23.
What interventions are being tested in trial NCT01761006?
The interventions under investigation include: NIOX MINO® (DEVICE).
Who is sponsoring clinical trial NCT01761006?
This trial is sponsored by Wake Forest University, which has 100 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.